How Should We Gauge the Risk/Benefit Relationship of Cryoprecipitate Transfusion Following Cardiac Operations. Ferraris VA. Ann Thorac Surg 2023 Apr 15:S0003-4975(23)00389.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ferraris VA. How Should We Gauge the Risk/Benefit Relationship of Cryoprecipitate Transfusion Following Cardiac Operations. Ann Thorac Surg 2023 Apr 15:S0003-4975(23)00389.
PMID: 37068570